PCRX
PCRX
US6951271005
Pacira BioSciences, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 726.411.000 700.966.000
3.6%
Cost of Revenue 149.749.000 170.428.000
12.1%
Gross Profit 576.662.000 530.538.000
8.7%
557.471.000 440.666.000
26.5%
Operating Income 19.191.000 89.872.000
78.6%
Pretax Income 16.874.000 -63.106.000
126.7%
Net Income Common Stockholders 7.034.000 -99.560.000
107.1%
-- --
--
-- --
--
ende